| [1] |
何彦安, 丁辉, 蔡岷, 等. 胆管结核误诊为壶腹周围癌一例并文献复习. 临床误诊误治, 2014, 27(7):42-44. doi:10.3969/j:issn.1002-3429.2014.07.016.
|
| [2] |
李建水, 张肇达, 唐勇. 1例肝门胆管结核及临床分析. 消化外科, 2005, 4(4):249-264. doi:10.3760/cma.j.issn.1673-9752.2005.04.028.
|
| [3] |
Acharya B, Acharya A, Gautam S, et al. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep, 2020, 47(5):4065-4075. doi:10.1007/s11033-020-05413-7.
|
| [4] |
Zampieri D, Mamolo MG. Hybridization Approach to Drug Discovery Inhibiting Mycobacterium tuberculosis-An Overview. Curr Top Med Chem, 2021, 21(9):777-788. doi:10.2174/1568026620666200819151342.
|
| [5] |
丁芹, 陈薇, 张胜康, 等. 肺外结核患者的营养状况调查及影响因素分析. 中国防痨杂志, 2023, 45(9):839-844. doi:10.19982/j.issn.1000-6621.20230221.
|
| [6] |
Fan ST, Ng IO, Choi TK, et al. Tuberculosis of the bile duct: a rare cause of biliary stricture. Am J Gastroenterol, 1989, 84(4):413-414.
pmid: 2929563
|
| [7] |
Alsawat KE, Aljebreen AM. Resolution of tuberculous biliary stricture after medical therapy. World J Gastroenterol, 2006, 12(7):1153-1156. doi:10.3748/wjg.v12.i7.1153.
|
| [8] |
张蕊, 时倩倩, 王仲秋. DCE-MRI、DWI和MRCP联合诊断肝外胆管癌临床价值研究. 实用肝脏病杂志, 2023, 26(6):923-926. doi:10.3969/j.issn.1672-5069.2023.06.039.
|
| [9] |
王宏博, 杨业发, 葛乃建. 肝外胆管癌的介入治疗现状与展望. 中国癌症杂志, 2022, 32(2):118-124. doi:10.19401/j.cnki.1007-3639.2022.02.003.
|
| [10] |
Ozin Y, Parlak E, Kilic ZM, et al. Sclerosing cholangitis-like changes in hepatobiliary tuberculosis. Turk J Gastroenterol, 2010, 21(1):50-53. doi:10.4318/tjg.2010.0049.
pmid: 20533114
|
| [11] |
Dyson JK, Beuers U, Jones D, et al. Primary sclerosing cholangitis. Lancet, 2018, 391(10139):2547-2559. doi:10.1016/S0140-6736(18)30300-3.
pmid: 29452711
|
| [12] |
Ch’Ng LS, Amzar H, Ghazali KC, et al. Imaging appearances of hepatic tuberculosis: experience with 12 patients. Clin Radiol, 2018, 73(3):311-321. doi:10.1016/j.crad.2017.10.016.
|
| [13] |
Karaosmanoglu AD, Onur MR, Sahani DV, et al. Hepatobiliary Tuberculosis: Imaging Findings. AJR Am J Roentgenol, 2016, 207(4):694-704. doi:10.2214/AJR.15.15926.
|
| [14] |
徐绽蕾, 邵国良. 肝外胆管细胞癌的影像学诊断现状与展望. 医学影像学杂志, 2020, 30(10):1936-1939.
|
| [15] |
Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis, 2004, 24(2):155-164. doi:10.1055/s-2004-828892.
pmid: 15192788
|
| [16] |
方伟军, 韩远远, 宋敏, 等. 陈旧性肺结核复燃的CT征象分析. 新发传染病电子杂志, 2021, 6(1):45-48. doi:10.19871/j.cnki.xfcrbzz.2021.01.010.
|
| [17] |
Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis, 2015, 32:87-93. doi:10.1016/j.ijid.2014.12.007.
pmid: 25809762
|
| [18] |
赵艳丽, 车南颖. 《结核病病理学诊断规范》团体标准解读. 中国防痨杂志, 2024, 46(4):371-374. doi:10.19982/j.issn.1000-6621.20240074.
|
| [19] |
中华医学会结核病学分会,结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017, 40(6):419-425. doi:10.3760/cma.j.issn.1001-0939.2017.06.005.
|
| [20] |
Mazlan MKN, Mohd Tazizi MHD, Ahmad R, et al. Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach. Antibiotics (Basel), 2021, 10(8):908. doi:10.3390/antibiotics10080908.
|
| [21] |
袁媛, 卢水华. 《世界卫生组织结核病整合指南模块4:药物敏感结核病的治疗》解读. 中国防痨杂志, 2022, 44(11):1122-1125. doi:10.19982/j.issn.1000-6621.20220330.
|
| [22] |
Shang P, Xia Y, Liu F, et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One, 2011, 6(7):e21836. doi:10.1371/journal.pone.0021836.
|
| [23] |
Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings. Radiographics, 2019, 39(7):2023-2037. doi:10.1148/rg.2019190109.
pmid: 31697616
|
| [24] |
董裕, 张福真, 尚媛媛, 等. GeneXpert MTB/RIF Ultra在肺外结核诊断中的研究进展. 中国防痨杂志, 2023, 45(12):1193-1197. doi:10.19982/j.issn.1000-6621.20230357.
|
| [25] |
Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol, 2019, 17(9):533-545. doi:10.1038/s41579-019-0214-5.
pmid: 31209399
|
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
